The AGS Beers Criteria®: Clinician's Guide to Safer Prescribing for Older Adults

The American Geriatrics Society (AGS) Beers Criteria® (2023 update) is the most widely used explicit tool for identifying potentially inappropriate medications (PIMs) in adults ≥65. It is not a "do not use" list — it is a decision-support framework to reduce adverse drug events (ADEs), hospitalizations, and mortality through informed prescribing.

Structure: 5 Categories

  1. PIMs for Most Older Adults (Table 2): Avoid regardless of condition (e.g., benzodiazepines, non-benzodiazepine hypnotics, first-gen antihistamines, anticholinergics, skeletal muscle relaxants, sliding-scale insulin, PPIs >8 weeks without indication).
  2. PIMs for Specific Conditions (Table 3): Avoid in certain diseases (e.g., NSAIDs in heart failure/CKD/ulcer history; antipsychotics in dementia; stimulants in anxiety/insomnia).
  3. Drugs to Use with Caution (Table 4): Benefit may outweigh risk with monitoring (e.g., aspirin >80, anticoagulants, SNRIs, vasodilators, hypoglycemics).
  4. Drug-Drug Interactions (Table 5): Clinically important pairs (e.g., ACEi + K-sparing diuretic = hyperkalemia; warfarin + NSAID = bleed; opioid + benzo = respiratory depression).
  5. Dose Adjustment for Renal Impairment (Table 6): eGFR-based dosing for 30+ drugs (e.g., gabapentin, metformin, DOACs, antibiotics).

Key 2023 Updates

  • Added: Gabapentinoids (gabapentin, pregabalin) — avoid initiating for chronic non-cancer pain; taper if possible (↑ falls, sedation, misuse).
  • Added: SGLT2 inhibitors — use with caution in frail/low BMI (euglycemic DKA risk).
  • Clarified: Antipsychotics in dementia — avoid except for severe agitation/psychosis with safety risk; time-limited, documented informed consent.
  • Updated: Anticholinergic burden — cumulative ACB scale ≥3 = high risk.
  • New: Deprescribing algorithms for PPIs, benzodiazepines, statins, bisphosphonates.

Clinical Workflow Integration

  1. Screen: Run Beers/STOPP/START at every visit via EHR clinical decision support (CDS).
  2. Prioritize: High-severity PIMs (fall risk, anticholinergic, CNS) + patient-reported symptoms.
  3. Communicate: "This medication may increase your risk of falls/confusion. Can we try…?"
  4. Deprescribe: Taper plan, monitor, restart only if necessary.
  5. Document: Reason for continuing PIM if benefit > risk (shared decision).

Beyond Beers: Complementary Tools

  • STOPP/START v3: More condition-specific; includes omissions (START).
  • MedStopper: Web/app algorithm ranking drugs by "stop priority."
  • FORTA: Fit fOR The Aged — classifies drugs A (indispensable) to D (avoid).
  • Drug Burden Index (DBI): Quantifies anticholinergic/sedative load.

Limitations

  • Not exhaustive — clinical judgment paramount.
  • Based on evidence quality (often low for oldest-old).
  • Does not capture all pharmacokinetic changes of aging.
  • US-centric; international versions exist (EU(7)-PIM, PRISCUS, NORGEP).

The Beers Criteria is a starting point for conversation, not a verdict. Safer prescribing = systematic review + patient-centered deprescribing + interdisciplinary collaboration.

Burns - Related Articles